Overview

Evaluate the Safety, Tolerability and PK of Different Formulations of Orally Administered Solabegron in Healthy Male Subjects

Status:
Completed

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of different formulations of orally administered solabegron in healthy male subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Velicept Therapeutics, Inc.

Treatments:

Solabegron